title: Imprecision Medicine: A One-Size-Fits-Many Approach for Muscle Dystrophy.
abstract: There is still no curative treatment for Duchenne muscular dystrophy (DMD). In this issue of Cell Stem Cell, Young et al. (2016) demonstrate a genome editing approach applicable to 60% of DMD patients with CRISPR/Cas9 using one pair of guide RNAs.
authors.affiliation: Department of Pathology, Institute for Stem Cell and Regenerative Medicine, Center for Cardiovascular Biology, University of Washington, Seattle, WA 98109, USA. Electronic address: ab67@uw.edu.
authors.forename: Astrid
authors.initials: A
authors.lastname: Breitbart
authors.affiliation: Department of Pathology, Institute for Stem Cell and Regenerative Medicine, Center for Cardiovascular Biology, University of Washington, Seattle, WA 98109, USA; Department of Bioengineering, Institute for Stem Cell and Regenerative Medicine, Center for Cardiovascular Biology, University of Washington, Seattle, WA 98109, USA; Department of Medicine/Cardiology, Institute for Stem Cell and Regenerative Medicine, Center for Cardiovascular Biology, University of Washington, Seattle, WA 98109, USA. Electronic address: murry@uw.edu.
authors.forename: Charles E
authors.initials: CE
authors.lastname: Murry
mesh_terms: D064113:CRISPR-Cas Systems; D016189:Dystrophin / Q000378:metabolism*; D005091:Exons; D015316:Genetic Therapy; D006801:Humans; D020388:Muscular Dystrophy, Duchenne
chemical_list: D016189:Dystrophin